These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27760191)

  • 1. A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction.
    Kwiatkowski S; Dołęgowska B; Kwiatkowska E; Rzepka R; Torbè A; Bednarek-Jędrzejek M
    PLoS One; 2016; 11(10):e0165060. PubMed ID: 27760191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction.
    Kwiatkowski S; Dołegowska B; Kwiatkowska E; Rzepka R; Marczuk N; Loj B; Torbè A
    J Perinat Med; 2017 Oct; 45(7):793-802. PubMed ID: 27865093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.
    Crispi F; Domínguez C; Llurba E; Martín-Gallán P; Cabero L; Gratacós E
    Am J Obstet Gynecol; 2006 Jul; 195(1):201-7. PubMed ID: 16545329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
    Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA
    Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion.
    Stepan H; Unversucht A; Wessel N; Faber R
    Hypertension; 2007 Apr; 49(4):818-24. PubMed ID: 17261644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics Identifies Placental Dysfunction and Confirms Flt-1 (FMS-Like Tyrosine Kinase Receptor 1) Biomarker Specificity.
    Austdal M; Silva GB; Bowe S; Thomsen LCV; Tangerås LH; Bjørge L; Bathen TF; Iversen AC
    Hypertension; 2019 Nov; 74(5):1136-1143. PubMed ID: 31495279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study.
    Raia-Barjat T; Prieux C; Gris JC; Chapelle C; Laporte S; Chauleur C
    J Matern Fetal Neonatal Med; 2019 Jan; 32(2):248-257. PubMed ID: 28889770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine growth restriction and placental gene expression in severe preeclampsia, comparing early-onset and late-onset forms.
    Nevalainen J; Skarp S; Savolainen ER; Ryynänen M; Järvenpää J
    J Perinat Med; 2017 Oct; 45(7):869-877. PubMed ID: 28593875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ; Åsvold BO; Eskild A
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction.
    Tjoa ML; Oudejans CB; van Vugt JM; Blankenstein MA; van Wijk IJ
    Hypertens Pregnancy; 2004; 23(2):171-89. PubMed ID: 15369650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction.
    Biron-Shental T; Sukenik-Halevy R; Sharon Y; Goldberg-Bittman L; Kidron D; Fejgin MD; Amiel A
    Am J Obstet Gynecol; 2010 Apr; 202(4):381.e1-7. PubMed ID: 20350645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction.
    Wang CN; Chang SD; Peng HH; Lee YS; Chang YL; Cheng PJ; Chao AS; Wang TH; Wang HS
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1431-41. PubMed ID: 20080845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.